.jpg)
An electronic health record-based prediction model successfully identified patients who were at the highest risk of developing type 2 diabetes up to 10 years later. Researchers from Kaiser Permanente presented the findings at the American Diabetes Association (ADA) meeting in New Orleans. The retrospective cohort study included 3,365,464 adults aged 18–70 receiving care at Kaiser Permanente Northern California from 2012 to 2024.
Despite steady demand for obesity medications, 49% of payers who do not currently cover GLP-1s for obesity would not do so at any price, a new report from Pharmaceutical Strategies Group (PSG) found. The 2026 Trends in Drug Benefit Design report drew insights from a survey of 237 benefits leaders across employers, health plans and unions. Nine in 10 respondents in the survey report being moderately or very concerned about the affordability of GLP-1 medications. Moreover, 72% report discontinuation rates are at least moderately influential in coverage decisions.
The 5 Areas Where Dr. Oz Says CMS Can Make Healthcare More Affordable
CMS Administrator Dr. Mehmet Oz is optimistic about Washington’s ability to bend the healthcare cost curve, he said during a Tuesday address at the HFMA Annual Conference in National Harbor, Maryland. Dr. Oz outlined the agency's strategy for making healthcare more affordable, touching on everything from Medicare fraud to drug pricing to nutrition.
Health systems race to rein in AI costs
Health systems across the U.S. are diving deep into AI. They’re also purchasing enterprise-wide AI accounts and encouraging their entire team to experiment and innovate with the technology to maximize potential before narrowing down use cases. The opportunities to solve tough problems in healthcare with AI are endless. But so are the expenses. Tokens are the units of data that large language models read and generate. But organizations often see tokens disappear quickly depending on how their teams use the technology.
House Appropriations Committee takes aim at CMS' WISeR pilot
A key legislative panel voted Tuesday to bar the Centers for Medicare & Medicaid Services from spending funds on a controversial prior authorization pilot. The House Appropriations Committee determined that "none of the funds made available in this Act or any other Act" should be used to implement the Wasteful and Inappropriate Services Reduction (WISeR) model, or another model that would add prior authorization to traditional Medicare.
Like us on Facebook
Follow us on Twitter
Follow us on LinkedIn